Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
8.63
+0.23 (2.80%)
At close: Oct 7, 2026, 4:00 PM EDT
8.63
+0.01 (0.06%)
After-hours: Oct 7, 2026, 6:01 PM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $19.71 million as of October 7, 2026. That makes Akari Therapeutics, the world's 37,295th most valuable company and 5,264th in the United States. Its market cap has decreased by 41.04% in one year.
Market Cap
19.71M
Enterprise Value
12.71M
1-Year Change
-41.04%
Global Rank
Country Rank
#5,264 United States
Category
ChartMarket Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $19.71M, a decrease of -93.24%. That is a compound annual growth rate of -21.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 19.71M | 48.96% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 22.95M |
| Quoin Pharmaceuticals | 22.00M |
| Cocrystal Pharma | 21.29M |
| Actuate Therapeutics | 19.50M |
| Psyence Biomedical | 19.35M |
| Neuphoria Therapeutics | 18.59M |
| Jasper Therapeutics | 18.57M |
| TScan Therapeutics | 18.21M |